1392150-51-4

Basic information

• Product Name: 5-[(3,5-difluorophenyl)thio]-1H-pyrazolo[3,4-b]pyridin-3-amine
• Synonyms: 5-[(3,5-difluorophenyl)thio]-1H-pyrazolo[3,4-b]pyridin-3-amine
• CAS NO: 1392150-51-4
• Molecular Weight: 278.285
• Mol File: 1392150-51-4.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 5-[(3,5-difluorophenyl)thio]-1H-pyrazolo[3,4-b]pyridin-3-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-[(3,5-difluorophenyl)thio]-1H-pyrazolo[3,4-b]pyridin-3-amine(1392150-51-4)
• EPA Substance Registry System: 5-[(3,5-difluorophenyl)thio]-1H-pyrazolo[3,4-b]pyridin-3-amine(1392150-51-4)

Safety Data

• Hazardous Substances Data: 1392150-51-4(Hazardous Substances Data)

Downstream Products

• 1392150-95-6 N-(5-((3,5-difluorophenyl)thio)-1H-pyrazolo[3,4-b]pyridin-3-yl)-4-(4-methylpiperazin-1-yl)-2-(2,2,2-trifluoro-N-(tetrahydro-2H-pyran-4-yl)acetamido)benzamide 
• 1392151-74-4 5-((3,5-difluorophenyl)thio)-N-(4-(4-methylpiperazin-1-yl)benzyl)-1H-pyrazolo[3,4-b]pyridin-3-amine 
• 1392151-76-6 1-(5-((3,5-difluorophenyl)thio)-1H-pyrazolo[3,4-b]pyridin-3-yl)-3-(4-(4-methylpiperazin-1-yl)phenyl)thiourea 
• 1392151-83-5 5-((3,5-difluorophenyl)thio)-N-(4-(4-methylpiperazin-1-yl)-2-((tetrahydro-2H-pyran-4-yl)amino)benzyl)-1H-pyrazolo[3,4-b]pyridin-3-amine 
• 1392151-79-9 N-(5-((3,5-difluorophenyl)thio)-1H-pyrazolo[3,4-b]pyridin-3-yl)-4-(4-methylpiperazin-1-yl)-2-((tetrahydro-2H-pyran-4-yl)amino)benzamide 
• 1392151-86-8 5-((3,5-difluorophenyl)sulfonyl)-1H-pyrazolo[3,4-b]pyridin-3-amine 

Relevant articles and documents

DERIVATIVES OF AZAINDAZOLE OR DIAZAINDAZOLE TYPE FOR TREATING PAIN

The present invention relates to a compound of following formula (I): or a pharmaceutically acceptable salt or solvate of same, a tautomer of same, or a stereoisomer or mixture of stereoisomers of same in any proportions, such as a mixture of enantiomers, notably a racemic mixture; for use in the treatment of pain.

DERIVATIVES OF AZAINDAZOLE OR DIAZAINDAZOLE TYPE AS MEDICAMENT

The present invention relates to a compound of following formula (I): or a pharmaceutically acceptable salt or solvate of same, a tautomer of same, or a stereoisomer or mixture of stereoisomers of same in any proportions, such as a mixture of enantiomers, notably a racemic mixture; as well as to the use of same as a drug, notably intended for the treatment of cancer, inflammation and neurodegenerative diseases such as Alzheimer's disease; to the use of same as a kinase inhibitor; to the pharmaceutical compositions comprising same; and to methods for the preparation of same.